Revolution Medicines, Inc. (RVMD) Tops Q3 EPS by 200c

Revolution Medicines, Inc. (NASDAQ: RVMD) reported Q3 EPS of $0.99, $2.00 better than the analyst estimate of ($1.01). Revenue for the quarter came in at $0 versus the consensus estimate of $750 thousand.

For earnings history and earnings-related data on Revolution Medicines, Inc. (RVMD) click here.

You May Also Be Interested In

• Paychex (PAYX) Tops Q1 EPS by 2c
• TD Cowen on Alaska Air (ALK): 'Can Alaska ReAccelerate?'
• AutoZone (AZO) PT Lowered to $4,230 at UBS Following 'Underwhelming' Q4 Print